Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Findings raise concern over bTB tests
Scientists have confirmed a case of Mycobacterium Microti infection in a cow in France.

Mycobacterium Microti infection confirmed in a cow in France

Scientists have confirmed a case of Mycobacterium Microti infection in a cow in France, raising concern over the reliability of diagnostic tests used for bovine TB (bTB) surveillance.

Reporting in Veterinary Record (Vol 180 No 17), researchers say the discovery follows an investigation of M Microti infection in a dairy goat in the same region.

Communicating the finding in 2015, the team demonstrated that the bacteria could be responsible for misleading diagnostic results for bTB.

In this latest study, researchers found that the suspected cattle herd had shared the same pasture with two bTB confirmed herds. As such, they submitted the herd for testing and culled one animal ‘with a doubtful result’ for direct diagnosis.

An analysis revealed the cow harboured the same genotype of M microti that was identified in the goat, as well as a badger that was living in the same area.

M Microti is a member of the Mycobacterium tuberculosis complex (MTBC), which also includes major human and animal pathogens like M tuberculosis and Mycobacterium bovis. It was first described as the cause of tuberculosis in small wild mammals, but it can also infect other species - including humans.

Previously in the UK, M microti has been isolated in skin test reactor cattle, demonstrating the risk of infection in livestock and of interference with bTB diagnosis.
The researchers believe that all these findings raise concerns about the reliability of diagnostic tests used for bTb surveillance.

‘The use of highly specific tests based on specific antigens such as ESAT6 and CFP10 (which are absent in M microti and already currently used in the interferon gamma test employed in France) are highly recommended to accurately identify M Bovis infection at antemortem examination,’ they write.

'At postmortem diagnosis, the use of specific molecular tools should be considered to rapidly distinguish pathogens within the MTBC and to avoid misleading diagnosis’.

The research was led by scientists from ANSES - the French agency for Food, Environmental and Occupational Health & Safety. 

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.